{"url":"https://lda.senate.gov/api/v1/filings/4d481dff-958e-4cb4-a196-641a6c8d607e/","filing_uuid":"4d481dff-958e-4cb4-a196-641a6c8d607e","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2019,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4d481dff-958e-4cb4-a196-641a6c8d607e/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tylynn Gordon","dt_posted":"2020-04-16T12:55:18.660000-04:00","termination_date":"2019-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 New Jersey Ave NW","registrant_address_2":"Suite 250","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":79175,"url":"https://lda.senate.gov/api/v1/registrants/79175/","house_registrant_id":37196,"name":"STRATEGIES 360","description":"Government affairs","address_1":"2200 6th Avenue","address_2":"Suite 780","address_3":null,"address_4":null,"city":"Seattle","state":"WA","state_display":"Washington","zip":"98121","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALAN CHAFFEE","contact_telephone":"+1 206-334-0822","dt_updated":"2026-07-22T12:32:46.665782-04:00"},"client":{"id":170538,"url":"https://lda.senate.gov/api/v1/clients/170538/","client_id":1003441,"name":"EMULATE THERAPEUTICS","general_description":"Clinical-stage therapeutic device company","client_government_entity":false,"client_self_select":null,"state":"WA","state_display":"Washington","country":"US","country_display":"United States of America","ppb_state":"WA","ppb_state_display":"Washington","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to medical device technology and FDA accelerated pathway","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24687,"prefix":"ms","prefix_display":"MS.","first_name":"TYLYNN","nickname":null,"middle_name":"R","last_name":"GORDON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67125,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"ELLERBE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}